The Diagnostic Accuracy of Colon Capsule Endoscopy in Inflammatory Bowel Disease-A Systematic Review and Meta-Analysis

• Published in: Diagnostics (Basel) 2024-09, Vol.14 (18), p.2056
• Main Authors: Lei, Ian Io, Thorndal, Camilla, Manzoor, Muhammad Shoaib, Parsons, Nicholas, Noble, Charlie, Huhulea, Cristiana, Koulaouzidis, Anastasios, Arasaradnam, Ramesh P
• Format: Article
• Language: English
• Subjects: Accuracy; Bias; Colitis; Colon; colon capsule endoscopy; colonic inflammation; colonic inflammatory conditions; Colonoscopy; Colorectal cancer; Crohn's disease; Diagnostic tests; Endoscopy; Gastrointestinal diseases; Inflammatory bowel disease; Medical research; Medicine, Experimental; Meta-analysis; non-polypoidal colonic conditions; panenteric capsule endoscopy; Patients; Sensitivity analysis; Software; Systematic Review
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics14182056

Colon capsule endoscopy (CCE) has regained popularity for lower gastrointestinal investigations since the COVID-19 pandemic. While there have been systematic reviews and meta-analyses on colonic polyp detection using CCE, there is a lack of comprehensive evidence concerning colonic inflammation. Therefore, this systematic review and meta-analysis aimed to assess the diagnostic accuracy of CCE for colonic inflammation, predominantly ulcerative colitis (UC) and Crohn's disease (CD). We systematically searched electronic databases (EMBASE, MEDLINE, PubMed Central, and Cochrane Library) for studies comparing the diagnostic accuracy between CCE and optical endoscopy as the standard reference. A bivariate random effect model was used for the meta-analysis. From 3797 publications, 23 studies involving 1353 patients were included. Nine studies focused on UC, and ten focused on CD. For UC, CCE showed a pooled sensitivity of 92% (95% CI, 88-95%), a specificity of 71% (95% CI, 35-92%), and an AUC of 0.93 (95% CI, 0.89-0.97). For CD, the pooled sensitivity was 92% (95% CI, 89-95%), and the specificity was 88% (95% CI, 84-92%), with an AUC of 0.87 (95% CI, 0.76-0.98). Overall, for inflammatory bowel disease, the pooled sensitivity, specificity, and AUC were 90% (95% CI, 85-93%), 76% (95% CI, 56-90%), and 0.92 (95% CI, 0.94-0.97), respectively. Despite the challenges around standardised disease scoring and the lack of histological confirmation, CCE performs well in diagnosing inflammatory bowel disease. It demonstrates high sensitivity in both UC and Crohn's terminal ileitis and colitis and high specificity in Crohn's disease. Further studies are needed to evaluate the diagnostic accuracy of other colonic inflammatory conditions.